In the high-stakes landscape of modern biological research, the ability to isolate a single, rare cell from a complex, heterogeneous...
The landscape of pharmaceutical manufacturing is undergoing a profound transformation. As the industry pivots from traditional, high-volume small-molecule drugs toward...
India’s biotechnology sector has reached a significant inflection point with the commissioning of a specialized antibody-drug conjugate (ADC) manufacturing facility...
In a significant development for the U.S. semiconductor landscape, President Donald Trump recently took to Truth Social to declare that...
The manufacturing of Advanced Therapy Medicinal Products (ATMPs)—including gene therapies and cell-based treatments—has long been hampered by the limitations of...
